Intellia Thera CS (NTLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 189,182 | 120,495 | 130,849 | 171,979 | 226,748 |
| Marketable Securities | 412,333 | 537,619 | 560,219 | 619,315 | 685,475 |
| Receivables | 8,517 | 8,854 | 12,329 | 36,427 | 36,456 |
| TOTAL | $639,863 | $710,902 | $757,211 | $884,043 | $998,330 |
| Non-Current Assets | |||||
| PPE Net | 27,381 | 28,763 | 30,273 | 32,075 | 32,760 |
| Investments And Advances | 260,215 | 286,567 | 248,805 | 162,090 | 111,629 |
| Other Non-Current Assets | 263,556 | 147,119 | 155,247 | 181,381 | 158,258 |
| TOTAL | $551,152 | $462,449 | $434,325 | $375,546 | $302,647 |
| Total Assets | $1,191,015 | $1,173,351 | $1,191,536 | $1,259,589 | $1,300,977 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 14,589 | 13,145 | 18,816 | 13,689 | 7,452 |
| Accrued Expenses | 55,355 | 51,206 | 45,127 | 43,276 | 67,017 |
| TOTAL | $110,851 | $105,683 | $105,090 | $97,912 | $115,208 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 20,661 | 22,155 | 22,184 | 22,184 | 22,140 |
| Other Non-Current Liabilities | 189,952 | 82,446 | 87,332 | 92,100 | 96,747 |
| TOTAL | $208,208 | $105,053 | $115,384 | $125,540 | $135,600 |
| Total Liabilities | $319,059 | $210,736 | $220,474 | $223,452 | $250,808 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 103,518 | 101,849 | 101,579 | 96,475 | 96,106 |
| Common Shares | 10 | 10 | 10 | 10 | 9 |
| Retained earnings | -2,177,400 | -2,048,502 | -1,912,790 | -1,765,815 | -1,658,379 |
| Other shareholders' equity | 605 | 3,297 | -1,155 | -947 | -2,258 |
| TOTAL | $871,956 | $962,615 | $971,062 | $1,036,137 | $1,050,169 |
| Total Liabilities And Equity | $1,191,015 | $1,173,351 | $1,191,536 | $1,259,589 | $1,300,977 |